Skip to main content

Articles

Page 24 of 39

  1. The optimal monitoring schedules and cutoff minimal residual disease (MRD) levels for the accurate prediction of relapse at all time points after allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...

    Authors: Ya-Zhen Qin, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Wei Han, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Yao Chen, Xiao-Dong Mo, Xiao-Su Zhao, Ying-Jun Chang, Kai-Yan Liu and Xiao-Jun Huang
    Citation: Journal of Hematology & Oncology 2017 10:44
    Content type: Research Published on:

  2. Numerous DNA-damaging cellular stresses, including oncogene activation and DNA-damage response (DDR), may lead to cellular senescence. Previous observations linked microRNA deregulation with altered senescent ...

    Authors: João Ramalho-Carvalho, Inês Graça, Antonio Gomez, Jorge Oliveira, Rui Henrique, Manel Esteller and Carmen Jerónimo
    Citation: Journal of Hematology & Oncology 2017 10:43
    Content type: Research Published on:

  3. We developed a novel murine monoclonal antibody (mAb) against the C-terminal α-helix of the human von Willebrand factor A2, designated SZ-179. We showed that SZ-179 inhibited the interactions between VWF and A...

    Authors: Lulu Zhang, Jian Su, Fei Shen, Zhenni Ma, Yiming Zhao, Lijun Xia and Changgeng Ruan
    Citation: Journal of Hematology & Oncology 2017 10:42
    Content type: Letter to the Editor Published on:

  4. Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is a heterogeneous malignancy characterized by distinct genetic and epigenetic abnormalities. Recent genome-wide DNA methyl...

    Authors: Yan Li, Qingyu Xu, Na Lv, Lili Wang, Hongmei Zhao, Xiuli Wang, Jing Guo, Chongjian Chen, Yonghui Li and Li Yu
    Citation: Journal of Hematology & Oncology 2017 10:41
    Content type: Review Published on:

  5. It is well established that caspase-1 exerts its biological activities through its downstream targets such as IL-1β, IL-18, and Sirt-1. The microarray datasets derived from various caspase-1 knockout tissues i...

    Authors: Ya-feng Li, Gayani Nanayakkara, Yu Sun, Xinyuan Li, Luqiao Wang, Ramon Cueto, Ying Shao, Hangfei Fu, Candice Johnson, Jiali Cheng, Xiongwen Chen, Wenhui Hu, Jun Yu, Eric T. Choi, Hong Wang and Xiao-feng Yang
    Citation: Journal of Hematology & Oncology 2017 10:40
    Content type: Research Published on:

  6. Methylation of N6 adenosine (m6A) is known to be important for diverse biological processes including gene expression control, translation of protein, and messenger RNA (mRNA) splicing. However, its role in the d...

    Authors: Chau-To Kwok, Amy D. Marshall, John E. J. Rasko and Justin J. L. Wong
    Citation: Journal of Hematology & Oncology 2017 10:39
    Content type: Letter to the Editor Published on:

    The Erratum to this article has been published in Journal of Hematology & Oncology 2017 10:49

  8. Klotho, is a transmembrane protein, performs as a circulating hormone and upstream modulator of the insulin-like growth factor-1 receptor (IGF-1R), fibroblast growth factor (FGF), and Wnt signaling pathways. T...

    Authors: Xiangxiang Zhou, Xiaosheng Fang, Yujie Jiang, Lingyun Geng, Xinyu Li, Ying Li, Kang Lu, Peipei Li, Xiao Lv and Xin Wang
    Citation: Journal of Hematology & Oncology 2017 10:37
    Content type: Research Published on:

  9. The macrophage, one of the several key immune cell types, is believed to be involved in tumorigenesis. However, the mechanism of macrophages promoting tumor progression is largely unknown.

    Authors: Yulei Chen, Siyuan Zhang, Qizhi Wang and Xiaobo Zhang
    Citation: Journal of Hematology & Oncology 2017 10:36
    Content type: Research Published on:

  10. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered the cornerstone in treatment of hematological malignancies. However, relapse of the hematological disease after allo-HSCT remains a ...

    Authors: Jun Liu, Jiang F. Zhong, Xi Zhang and Cheng Zhang
    Citation: Journal of Hematology & Oncology 2017 10:35
    Content type: Review Published on:

  11. The current success of targeted inhibition against cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed Death 1/Programmed Death Ligand 1 (PD-1/PD-L1, herein collectively referred to as PD) path...

    Authors: Jun Wang, Ruirong Yuan, Wenru Song, Jingwei Sun, Delong Liu and Zihai Li
    Citation: Journal of Hematology & Oncology 2017 10:34
    Content type: Review Published on:

  12. Thrombospondin-2 (TSP-2) is a secreted matricellular glycoprotein that is found to mediate cell-to-extracellular matrix attachment and participates in many physiological and pathological processes. The express...

    Authors: Po-Chun Chen, Chih-Hsin Tang, Liang-Wei Lin, Chun-Hao Tsai, Cheng-Ying Chu, Tien-Huang Lin and Yuan-Li Huang
    Citation: Journal of Hematology & Oncology 2017 10:33
    Content type: Research Published on:

  13. The emerging roles of microRNAs (miRs) have been deeply investigated in cancer. However, the role of miR-194 in human laryngeal squamous cell carcinoma (LSCC) is still unclear. Here, we have demonstrated that ...

    Authors: Pei Li, Yang Yang, Hui Liu, An-Kui Yang, Jin-Ming Di, Guang-Mou Tan, Hai-Feng Wang, Jian-Ge Qiu, Wen-Ji Zhang, Qi-Wei Jiang, Di-Wei Zheng, Yao Chen, Meng-Ning Wei, Jia-Rong Huang, Kun Wang, Zhi Shi…
    Citation: Journal of Hematology & Oncology 2017 10:32
    Content type: Letter to the Editor Published on:

  14. The impact of the use of anti-thymocyte globulin (ATG) in allogeneic stem cell transplantation performed with HLA-identical sibling donors following fludarabine and 4 days intravenous busulfan myeloablative co...

    Authors: Marie Thérèse Rubio, Maud D’Aveni-Piney, Myriam Labopin, Rose-Marie Hamladji, Miguel A. Sanz, Didier Blaise, Hakan Ozdogu, Etienne Daguindeau, Carlos Richard, Stella Santarone, Giuseppe Irrera, Ibrahim Yakoub-Agha, Moshe Yeshurun, Jose L. Diez-Martin, Mohamad Mohty, Bipin N Savani…
    Citation: Journal of Hematology & Oncology 2017 10:31
    Content type: Research Published on:

  15. Wilms’ tumor gene 1 (WT1) expression is a well-known predictor for relapse in acute myeloid leukemia. We monitored WT1 decrement along the treatment course to identify its significant role as a marker for residua...

    Authors: Jae-Ho Yoon, Hee-Je Kim, Dae-Hun Kwak, Sung-Soo Park, Young-Woo Jeon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee and Woo-Sung Min
    Citation: Journal of Hematology & Oncology 2017 10:30
    Content type: Letter to the Editor Published on:

  16. Epigenetics has been known to play a critical role in regulating the malignant phenotype. This study was designed to examine the expression of DOT1L (histone 3 lysine 79 methyltransferase) and H3K79 methylatio...

    Authors: Xiaoxue Zhang, Dan Liu, Mengchen Li, Canhui Cao, Dongyi Wan, Bixin Xi, Wenqian Li, Jiahong Tan, Ji Wang, Zhongcai Wu, Ding Ma and Qinglei Gao
    Citation: Journal of Hematology & Oncology 2017 10:29
    Content type: Research Published on:

  17. Tumor metastasis is an essential cause of the poor prognosis of colon cancer. DC-SIGNR is a C-type lectin that is frequently found on human liver sinusoidal endothelial cells. LSECtin, which is a homologue of ...

    Authors: Heya Na, Xiaoli Liu, Xiaomeng Li, Xinsheng Zhang, Yu Wang, Zhaohui Wang, Menglang Yuan, Yu Zhang, Shuangyi Ren and Yunfei Zuo
    Citation: Journal of Hematology & Oncology 2017 10:28
    Content type: Research Published on:

  18. Hematopoiesis is probably the best-understood stem cell differentiation system; hematopoietic stem cell (HSC) transplantation represents the most widely used regenerative therapy. The classical view of lineage...

    Authors: Fang Ye, Wentao Huang and Guoji Guo
    Citation: Journal of Hematology & Oncology 2017 10:27
    Content type: Review Published on:

  19. CBFA2T3-GLIS2 is a fusion gene found in 17% of non-Down syndrome acute megakaryoblastic leukemia (non-DS AMKL, FAB M7) and in 8% of pediatric cytogenetically normal acute myeloid leuke...

    Authors: Riccardo Masetti, Salvatore Nicola Bertuccio, Annalisa Astolfi, Francesca Chiarini, Annalisa Lonetti, Valentina Indio, Matilde De Luca, Jessica Bandini, Salvatore Serravalle, Monica Franzoni, Martina Pigazzi, Alberto Maria Martelli, Giuseppe Basso, Franco Locatelli and Andrea Pession
    Citation: Journal of Hematology & Oncology 2017 10:26
    Content type: Letter to the Editor Published on:

  20. Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable identical donors and those who are refrac...

    Authors: Lan-Ping Xu, Song Jin, Shun-Qing Wang, Ling-Hui Xia, Hai Bai, Su-Jun Gao, Qi-Fa Liu, Jian-Min Wang, Xin Wang, Ming Jiang, Xi Zhang, De-Pei Wu and Xiao-Jun Huang
    Citation: Journal of Hematology & Oncology 2017 10:25
    Content type: Research Published on:

  21. In the absence of a HLA-matched related or matched unrelated donor, allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or haploidentical donors are potential alternatives for pati...

    Authors: Simona Piemontese, F. Ciceri, M. Labopin, W. Arcese, S. Kyrcz-Krzemien, S. Santarone, H. Huang, D. Beelen, N. C. Gorin, C. Craddock, Z. Gulbas, A. Bacigalupo, M. Mohty and A. Nagler
    Citation: Journal of Hematology & Oncology 2017 10:24
    Content type: Research Published on:

  22. Activated protein C/endothelial protein C receptor (APC/EPCR) axis is physiologically involved in anticoagulant and cytoprotective activities in endothelial cells. Emerging evidence indicates that EPCR also pl...

    Authors: Naiara Perurena, Carolina Zandueta, Susana Martínez-Canarias, Haritz Moreno, Silvestre Vicent, Ana S. Almeida, Elisabet Guruceaga, Roger R. Gomis, Marta Santisteban, Mikala Egeblad, José Hermida and Fernando Lecanda
    Citation: Journal of Hematology & Oncology 2017 10:23
    Content type: Research Published on:

  23. To assess the efficacy and safety of fruquintinib, a vascular endothelial growth factor receptor (VEGFR) inhibitor, in metastatic colorectal cancer (mCRC) patients.

    Authors: Rui-Hua Xu, Jin Li, Yuxian Bai, Jianming Xu, Tianshu Liu, Lin Shen, Liwei Wang, Hongming Pan, Junning Cao, Dongsheng Zhang, Songhua Fan, Ye Hua and Weiguo Su
    Citation: Journal of Hematology & Oncology 2017 10:22
    Content type: Research Published on:

  24. The determinants of clinical responses after autologous hematopoietic stem cell transplantation (aHSCT) in systemic sclerosis (SSc) are still unraveled. We analyzed long-term immune reconstitution (IR) and T c...

    Authors: Dominique Farge, Lucas C. M. Arruda, Fanny Brigant, Emmanuel Clave, Corinne Douay, Zora Marjanovic, Christophe Deligny, Guitta Maki, Eliane Gluckman, Antoine Toubert and Helene Moins-Teisserenc
    Citation: Journal of Hematology & Oncology 2017 10:21
    Content type: Rapid communication Published on:

  25. Acute myeloid leukaemia (AML) with 17p abnormalities (abn(17p)) carries a very poor prognosis due to high refractoriness to conventional chemotherapy, and allogeneic stem cell transplantation (allo-SCT) appear...

    Authors: Xavier Poiré, Myriam Labopin, Johan Maertens, Ibrahim Yakoub-Agha, Didier Blaise, Norbert Ifrah, Gérard Socié, Tobias Gedde-Dhal, Nicolaas Schaap, Jan J. Cornelissen, Stéphane Vigouroux, Jaime Sanz, Lucienne Michaux, Jordi Esteve, Mohamad Mohty and Arnon Nagler
    Citation: Journal of Hematology & Oncology 2017 10:20
    Content type: Research Published on:

  26. The value of microRNAs (miRNAs) as novel targets for cancer therapy is now widely recognized. However, no information is currently available on the expression/functional role of miRNAs in diffuse malignant per...

    Authors: Rihan El Bezawy, Michelandrea De Cesare, Marzia Pennati, Marcello Deraco, Paolo Gandellini, Valentina Zuco and Nadia Zaffaroni
    Citation: Journal of Hematology & Oncology 2017 10:19
    Content type: Research Published on:

  27. Thrombocytopenia 2 (THC2) is an inherited disorder caused by monoallelic single nucleotide substitutions in the 5’UTR of the ANKRD26 gene. Patients have thrombocytopenia and increased risk of myeloid malignancies...

    Authors: Caterina Marconi, Ilaria Canobbio, Valeria Bozzi, Tommaso Pippucci, Giorgia Simonetti, Federica Melazzini, Silvia Angori, Giovanni Martinelli, Giuseppe Saglio, Mauro Torti, Ira Pastan, Marco Seri and Alessandro Pecci
    Citation: Journal of Hematology & Oncology 2017 10:18
    Content type: Letter to the Editor Published on:

  28. Aerobic glycolysis, a hallmark of cancer, is characterized by increased metabolism of glucose and production of lactate in normaxia. Recently, pyruvate kinase M2 (PKM2) has been identified as a key player for ...

    Authors: Zhimin Gu, Jiliang Xia, Hongwei Xu, Ivana Frech, Guido Tricot and Fenghuang Zhan
    Citation: Journal of Hematology & Oncology 2017 10:17
    Content type: Research Published on:

  29. We have previously shown that in pancreatic ductal adenocarcinoma (PDA) cells, the glycolytic enzyme alpha-enolase (ENO1) also acts as a plasminogen receptor and promotes invasion and metastasis formation. Mor...

    Authors: Moitza Principe, Simone Borgoni, Mariafrancesca Cascione, Michelle Samuel Chattaragada, Sammy Ferri-Borgogno, Michela Capello, Sara Bulfamante, Jennifer Chapelle, Francesca Di Modugno, Paola Defilippi, Paola Nisticò, Paola Cappello, Chiara Riganti, Stefano Leporatti and Francesco Novelli
    Citation: Journal of Hematology & Oncology 2017 10:16
    Content type: Research Published on:

  30. Pegylated interferon (peg-IFN) was proven by phase II trials to be effective in polycythemia vera (PV); however, it is not clear whether it could improve patient outcome compared to hydroxyurea (HU). Here, we ...

    Authors: Elena Crisà, Marco Cerrano, Eloise Beggiato, Giulia Benevolo, Giuseppe Lanzarone, Paola Maria Manzini, Alessandra Borchiellini, Ludovica Riera, Mario Boccadoro and Dario Ferrero
    Citation: Journal of Hematology & Oncology 2017 10:15
    Content type: Letter to the Editor Published on:

  31. The causative role of the pro-inflammatory cytokine IL-6 in prostate cancer progression has been well established at molecular level. However, whether and how IL-6 may play a role in prostate cancer risk and d...

    Authors: Gang Liu, Jinyu Zhang, Lewis Frey, Xiao Gang, Kongming Wu, Qian Liu, Michael Lilly and Jennifer Wu
    Citation: Journal of Hematology & Oncology 2017 10:14
    Content type: Research Published on:

  32. Indatuximab ravtansine is a monoclonal antibody-linked cytotoxic agent that specifically targets CD138-expressing cells. Monotherapy has been shown to significantly inhibit multiple myeloma tumour growth in vi...

    Authors: Kurt Schönfeld, Chantal Zuber, Jan Pinkas, Thomas Häder, Katrin Bernöster and Christoph Uherek
    Citation: Journal of Hematology & Oncology 2017 10:13
    Content type: Letter to the Editor Published on:

  33. Cluster of differentiation 47 (CD47) (also known as integrin-associated protein) is a ubiquitously expressed glycoprotein of the immunoglobulin superfamily that plays a critical role in self-recognition. Vario...

    Authors: Xiaojuan Liu, Hyunwoo Kwon, Zihai Li and Yang-xin Fu
    Citation: Journal of Hematology & Oncology 2017 10:12
    Content type: Review Published on:

  34. Head and neck squamous cell carcinoma (HNSCC) represents a unique and major health concern worldwide. Significant increases in glucose uptake and aerobic glycolysis have been observed in HNSCC cells. Glucose t...

    Authors: Yu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, Chia-Yi Su, Yuang-Feng Lin, Chi-Long Chen, Ming-Huang Chen, Peter Mu-Hsin Chang, Alex T. H. Wu and Michael Hsiao
    Citation: Journal of Hematology & Oncology 2017 10:11
    Content type: Research Published on:

  35. Osteosarcoma is the most common primary bone cancer affecting children and adolescents worldwide. Despite an incidence of three cases per million annually, it accounts for an inordinate amount of morbidity and...

    Authors: Pablo Angulo, Gaurav Kaushik, Dharmalingam Subramaniam, Prasad Dandawate, Kathleen Neville, Katherine Chastain and Shrikant Anant
    Citation: Journal of Hematology & Oncology 2017 10:10
    Content type: Review Published on:

  36. There is increasing evidence of a constitutive activation of Akt in pancreatic ductal adenocarcinoma (PDAC), associated with poor prognosis and chemoresistance. Therefore, we evaluated the expression of phosph...

    Authors: Daniela Massihnia, Amir Avan, Niccola Funel, Mina Maftouh, Anne van Krieken, Carlotta Granchi, Rajiv Raktoe, Ugo Boggi, Babette Aicher, Filippo Minutolo, Antonio Russo, Leticia G. Leon, Godefridus J. Peters and Elisa Giovannetti
    Citation: Journal of Hematology & Oncology 2017 10:9
    Content type: Research Published on:

  37. Since the discovery of microRNAs (miRNAs) in the early 1990s, these small molecules have been increasingly recognized as key players in the regulation of critical biological processes. They have also been impl...

    Authors: John E.J. Rasko and Justin J.-L. Wong
    Citation: Journal of Hematology & Oncology 2017 10:8
    Content type: Review Published on:

  38. The difference in clinical features and treatment outcomes between localized sinonasal diffuse large B cell lymphoma (SN-DLBCL) and sinonasal extranodal NK/T cell lymphoma (SN-ENKTL) is unclear. Therefore, we ...

    Authors: Yu Huang, Bo Jia, Shiyu Jiang, Shengyu Zhou, Jianliang Yang, Peng Liu, Lin Gui, Xiaohui He, Yan Qin, Yan Sun and Yuankai Shi
    Citation: Journal of Hematology & Oncology 2017 10:7
    Content type: Letter to the Editor Published on:

  39. The X-linked inhibitor of apoptosis protein (XIAP) is a well-known potent apoptosis suppressor and also participates in cancer cell biological behaviors, therefore attracting great attentions as a potential an...

    Authors: Chao Huang, Xingruo Zeng, Guosong Jiang, Xin Liao, Claire Liu, Jingxia Li, Honglei Jin, Junlan Zhu, Hong Sun, Xue-Ru Wu and Chuanshu Huang
    Citation: Journal of Hematology & Oncology 2017 10:6
    Content type: Research Published on:

  40. Glioblastoma recurrence after treatment with the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab is characterized by a highly infiltrative and malignant behavior that renders surgical excis...

    Authors: Giovanni Luca Gravina, Andrea Mancini, Francesco Marampon, Alessandro Colapietro, Simona Delle Monache, Roberta Sferra, Flora Vitale, Peter J. Richardson, Lee Patient, Stephen Burbidge and Claudio Festuccia
    Citation: Journal of Hematology & Oncology 2017 10:5
    Content type: Research Published on:

  41. Cholangiocarcinoma (CCA) is one of the most fatal malignant tumors with increasing incidence, mortality, and insensitivity to traditional chemo-radiotherapy and targeted therapy. Chimeric antigen receptor-modi...

    Authors: Kai-chao Feng, Ye-lei Guo, Yang Liu, Han-ren Dai, Yao Wang, Hai-yan Lv, Jian-hua Huang, Qing-ming Yang and Wei-dong Han
    Citation: Journal of Hematology & Oncology 2017 10:4
    Content type: Case report Published on:

  42. Metastatic melanoma is an aggressive form of skin cancer with a high mortality rate and the fastest growing global incidence rate of all malignancies. The introduction of BRAF/MEK inhibitor combinations has yi...

    Authors: Adil Daud, Japinder Gill, Sheily Kamra, Lei Chen and Amit Ahuja
    Citation: Journal of Hematology & Oncology 2017 10:3
    Content type: Research Published on:

  43. Circular RNAs (circRNAs) are a class of endogendous RNAs that form a covalently closed continuous loop and exist extensively in mammalian cells. Majority of circRNAs are conserved across species and often show...

    Authors: Yeping Dong, Dan He, Zhenzi Peng, Wei Peng, Wenwen Shi, Jun Wang, Bin Li, Chunfang Zhang and Chaojun Duan
    Citation: Journal of Hematology & Oncology 2017 10:2
    Content type: Review Published on:

  45. Lung cancer continues to be the most common cause of cancer-related mortality worldwide. Recent advances in molecular diagnostics and immunotherapeutics have propelled the rapid development of novel treatment ...

    Authors: Bhagirathbhai Dholaria, William Hammond, Amanda Shreders and Yanyan Lou
    Citation: Journal of Hematology & Oncology 2016 9:138
    Content type: Review Published on:

  46. Pacritinib (SB1518) is a highly selective kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CFS1R. This multicenter phase 1/2 study evaluated the maximum tolerated dose (MTD), safety, and clinical a...

    Authors: Srdan Verstovsek, Olatoyosi Odenike, Jack W. Singer, Tanya Granston, Suliman Al-Fayoumi and H. Joachim Deeg
    Citation: Journal of Hematology & Oncology 2016 9:137
    Content type: Research Published on:

  47. Megakaryocytic cell maturation involves polyploidization, and megakaryocyte (MK) ploidy correlates with their maturation and platelet production. Retardation of MK maturation is closely associated with poor MK...

    Authors: Nick Huang, Mabel Lou, Hua Liu, Cecilia Avila and Yupo Ma
    Citation: Journal of Hematology & Oncology 2016 9:136
    Content type: Research Published on:

  48. Inappropriate activation of c-mesenchymal-epithelial transition (MET), the receptor tyrosine kinase (RTK) for hepatocyte growth factor (HGF), has been implicated in tumorigenesis and represented a promising th...

    Authors: Bao Quoc Lam, Lu Dai and Zhiqiang Qin
    Citation: Journal of Hematology & Oncology 2016 9:135
    Content type: Review Published on:

  49. Anti-cancer immune responses may contribute to the control of tumors after conventional chemotherapy, and different observations have indicated that chemotherapeutic agents can induce immune responses resultin...

    Authors: Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, Alessandra Zingoni, Alessandra Soriani, Elisabetta Vulpis, Cristiana Borrelli, Beatrice Zitti, Maria Teresa Petrucci, Maria Rosaria Ricciardi, Rosa Molfetta, Rossella Paolini, Angela Santoni and Marco Cippitelli
    Citation: Journal of Hematology & Oncology 2016 9:134
    Content type: Research Published on:

  50. Authors: George S. Laszlo, Todd A. Alonzo, Chelsea J. Gudgeon, Kimberly H. Harrington, Alex Kentsis, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis, Soheil Meshinchi and Roland B. Walter
    Citation: Journal of Hematology & Oncology 2016 9:133
    Content type: Erratum Published on:

    The original article was published in Journal of Hematology & Oncology 2015 8:115

JHO logo
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    28.5 - 2-year Impact Factor
    23.1 - 5-year Impact Factor
    4.045 - SNIP (Source Normalized Impact per Paper)
    6.046 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    59 days submission to accept (Median)

    2023 Usage 
    3,173,795 downloads
    2,671 Altmetric mentions

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here. 

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us